Lankenau Institute for Medical Research
-
Penn Wynne Scientist Recognized Among World’s Leading Inventors
A longtime research leader at Penn Wynne’s Lankenau Medical Center is being recognized nationally for his impact on medical innovation,…
-
Main Line Health Rebounds with $4M Profit and Regional Growth Plans
Main Line Health has bounced back into the black after a tough year, reports John George for the Philadelphia Business…
-
Main Line Health COO Earns Patent for Life-Saving Invention
Main Line Health Executive VP and COO, Barbara Wadsworth, is now a U.S. patent holder for a life-saving medical device,…
-
Main Line Health Scientist on a Quest to Find the Secret to Regeneration
Regrowing nerves and healing wounds without scarring? It might seem a little too sci-fi right now, but one Main Line…
-
Lankenau Researcher Provides Groundbreaking Resource to Further Fight COVID-19
Dr. Sunil Thomas — a researcher at the Lankenau Institute of Medical Research in Wynnewood — has published the world’s…
-
Main Line Health Joins Forces With L2C Partners, Early Charm Ventures to Bring Innovations Created By Nurses to Commercialization
Main Line Health is joining forces with L2C Partners and Early Charm Ventures to bring innovations developed by its nursing…
-
Wynnewood-based Lankenau Institute for Medical Research Creates Rapid Test for COVID-19 Delta Variant Detection
Researchers at Wynnewood-based Lankenau Institute for Medical Research have developed a rapid diagnostic test to detect the Delta variant in…
-
MLH Researcher Receives Lifetime Achievement Award from American College of Cardiology
Dr. Charles Antzelevitch, professor and executive director of cardiovascular research at Main Line Health’s Lankenau Institute for Medical Research, has…
-
Wynnewood-Based Biotech Startup Taps Into LIMR’s Cell Glow Technology to Improve Production of Antibodies
Wynnewood-based OCMS Bio, a new life sciences startup, believes it has found a better way to produce monoclonal antibodies by…
-
Lankenau Research Director Doesn’t Skip a Beat, Wins Heart Rhythm Society Award
Charles Antzelevitch, Executive Director of the Cardiovascular Research Program at Wynewood’s Lankenau Institute for Medical Research, was named the winner…
-
Hatfield’s Genisphere Partners with Lankenau to Find New Approach to Treating Ovarian Cancer
Scientists at Genisphere, a biotech company in Hatfield, have partnered with a group of peers at Main Line Health’s Lankenau…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
